TickerFactsScreenerDevelopers

Clearside Biomedical, Inc. (CLSDQ) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$10.74M2014: -$19.21M2015: -$36.66M2016: $71.66M2017: $21.41M2018: $23.62M2019: $11.16M2020: $8.76M2021: $37.98M2022: $10.61M2023: -$15.91M2024: -$38.85M-$38.85M
2013Shareholders' Equity (USD)2024
Fiscal YearShareholders' EquityChange YoY
2024-$38.85M-144.2%
2023-$15.91M-250.0%
2022$10.61M-72.1%
2021$37.98M+333.4%
2020$8.76M-21.5%
2019$11.16M-52.8%
2018$23.62M+10.3%
2017$21.41M-70.1%
2016$71.66M+295.5%
2015-$36.66M-90.8%
2014-$19.21M-78.9%
2013-$10.74M—